Member Info for Blockbuster1

60 percent of 200DMA

With S3 support now breached I can certainly see that level and possibly £1.20...........

TA shows S3 at £1.66. That appears to be holding, I expect S3 to be tested and then if that holds and there's a bounce off S3 then I intend to start a dip feed in.......... The concern is if S3 does not hold and prove to be the bottom.

TA shows S3 at £1.66. That appears to be holding, I expect S3 to be tested and then if that holds and there's a bounce off S3 then I intend to start a dip feed in..........

It appears there are some posters on here with very strong opinions and only want positive comments. A balanced view and perspective I think are more important than ego worshiping. I'm still looking for an entry point but think there's further to slide yet. No buying momentum at all. Any thoughts on where this will bottom appreciated........

Just curious as to why the target selected and commencement of P1 trials will move the share price? We already know what disease types that are being targeted and that we are going into P1. So surely these things are already priced in? TIA.........

Hi elcap
No. I've not invested here previously and not currently invested. There's a bit of noise around this share so am keen to understand more. It looks interesting but quite a few fundamental questions with loose threads. That makes me nervous. These been no monetisation of any of its assets in its history. Clearly that has to change for value to be realised and I'm not seeing associations, other than investors, that will change that. And that's a concern. I appreciate the tempo of the space and the risk too. But usually there's some association by this time. I'd really appreciate any input on this.

Very funny old bean. When you have only one side of a story you have no story at all. The smart person considers all aspects and then acts. When you become blinded by prejudice then you become frozen to act, until it's too late of course.

Hi Cereus

That's the question I'm asking myself before investing too. Are big pharma not interested in Sareum or is Sareum not interested in big pharma YET. The answer to that question provides the answer to the value to be realised. Anyone else care to comment on this killer question?

Anyone have a sense where the bottom is? I see the share has bee fairly stable in and around £2 for the last number of weeks now despite wider market volatility. Do you see this trading in this £1.90 - £2.25 channel until further news or is their an opinion this might fallback further with no news and quiet summer trading months? Thanks in advance for your thoughts........

Thanks for the responses, much appreciated. I think I'll sit back and just watch the movement over the next 6 - 8 weeks. This could prove to be a very good entry point but that's just not absolutely clear to me right now.

Looking to come onboard. I've followed the share and read the board for a few weeks now. Some great posts. What's the view on P1 selection making a difference. Is it worth waiting to see or is thought stepping in now is a safe entry point,?